Kate Miller

Kate Miller serves as Coordinator of Science and Partnerships at the Population Health Research Network, affiliated with The University of Western Australia. She holds a doctoral degree (indicated by 'Dr' title) and maintains an active research profile with an h-index of 165 across 18 research outputs including articles, a doctoral thesis, and a preprint.

Dr. Miller specializes in epidemiological surveillance methodologies with a focus on Group A Streptococcal diseases and their complications. Her research spans vaccine development frameworks, disease burden assessment, antibiotic stewardship, and data standardization for public health. She has made significant contributions to standardizing surveillance approaches for conditions like streptococcal pharyngitis and poststreptococcal glomerulonephritis, with her work directly informing vaccine development strategies.

Her publication record reveals a strategic research trajectory focused on addressing critical gaps in infectious disease control. Recent work examines antibiotic consumption patterns for sore throat and models the potential impact of Group A Streptococcus vaccines. She has developed systematic frameworks for prioritizing burden of disease data and harmonizing surveillance methodologies across international settings.

Dr. Miller's research has substantial policy impact, with multiple articles referenced in policy sources and clinical guidelines. Her work has been featured in numerous news outlets and demonstrates strong academic engagement with significant readership on platforms like Mendeley.

As Coordinator of Science and Partnerships, she manages research collaborations and likely oversees multiple projects within the Population Health Research Network. Her research contributes to United Nations Sustainable Development Goals related to health and wellbeing, aligning with global efforts to reduce infectious disease burden.